Former Woodside Energy boss Peter Coleman takes helm at PYC Therapeutics following board crisis and managing director's brief resignation. Key leadership change aims to restore investor confidence.
NeuroScientific Biopharmaceuticals has dosed a fourth patient with its StemSmart stem-cell therapy for fistulising Crohn's disease, marking a key step for the Australian biotech. Discover the potential of this game-changing treatment.
Two Western Australian researchers have claimed Australia's most prestigious science awards for developing revolutionary technology that could transform emergency medicine worldwide.
University of Wollongong researchers develop groundbreaking implant technology that could transform pancreatic cancer treatment in Australian healthcare.